Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-21-000178
Filing Date
2021-02-12
Accepted
2021-02-12 16:57:01
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 SCEDULE 13G ss192038_sc13g.htm SC 13G 55284
2 JOINT FILING AGREEMENT ss192038_ex99a.htm EX-99.A 9901
  Complete submission text file 0000947871-21-000178.txt   66875
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88225 | Film No.: 21628971
SIC: 2834 Pharmaceutical Preparations